An anti Covid-19 vaccine developed by US pharma firm Pfizer and Germany's BioNTech has been approved for use in France by the country's top health authority, the Haute Autorité de la santé (HAS), with vaccinations due to start on a voluntazry basis on Sunday, with a priority given for those most at risk.
France's top health authority has formally approved the Pfizer-BioNTech Covid-19 vaccine, giving the green light to the nationwide inoculation campaign that is to start on December 27th, although the Haute Autorité de la santé (HAS) says some questions remain, reports Radio France Internationale.
